Table 1. Socio-demographic and clinical characteristics of HC and PD subjects.
Characteristics | HC (n = 80) | PD (n = 80) | p value | |
Gender (men %) | 50% | 50% | – | |
Age (years) | 59.5±9.5 | 59.2±9.9 | 0.833 | |
Education (years ) | 12.3±3.8 | 12.6±3.7 | 0.645 | |
MMSE (score) | 29.2±1.2 | 28.5±2.1 | 0.0122 | |
BDI total (score) | 5.3±4.3 | 10.1±8.0 | <0.0001 | |
BDI PSY (score) | 3.1±2.9 | 5.6±5.2 | 0.0003 | |
BDI SOM (score) | 2.2±2.0 | 4.5±3.3 | <0.0001 | |
Disease duration (years) | – | 4.6±3.8 | – | |
Hoehn & Yahr (%) | stage 1 | – | 25% | – |
stage 1.5 | – | 25% | – | |
stage 2 | – | 32.9% | – | |
stage 2.5 | – | 11.8% | – | |
stage 3 | – | 5.3% | – | |
stage >3 | – | 0% | – | |
Hoehn & Yahr stage (score) | – | 1.74±0.57 | – | |
UPDRS III (score) | – | 17.4±9.5 | – | |
L-dopa (mg/day) | – | 263.2±287.1 | – | |
DA-LED (mg/day) | – | 202.0±271.0 | – | |
Total LED (mg/day) | – | 465.2±389.8 | – |
Values are expressed as mean ± SD or percentage of subjects (%).